Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)
1 September 2025 (13:15 - 14:00)
Organised by: 
About the speaker
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
7 More presentations in this session
Doctor F. Bruno (Turin, IT)
Doctor M. Ferreira (Funchal, PT)
Doctor N. Nakamura (Isehara, JP)
Access the full session
The Event
ESC Congress 2025
1 September 2025
13:15 CET
You may be interested in
Congress Presentation
Congress Presentation
